Lundbeck has a clear mission: improving the quality of living for individuals suffering from psychiatric or neurological illnesses. In 1961, Lundbeck Arzneimittel Ges.m.b.H. was incorporated in Austria as subsidiary of the Danish H. Lundbeck A/S. In 1988, it was decided to specialise in the central nervous system. Lundbeck is the only pharmaceutical company with this particular focus. The company employs about 5,500 individuals in 55 countries, Lundbeck medicinal products for the treatment of depression, schizophrenia, Alzheimer´s or Parkinson´s disease as well as sleep disorders have been authorised in 90 countries.
„When it comes to market research, marketmind has been among our preferred partners for years. This is owing to the competent, friendly team, flexibility regarding our requirements, and of course also an excellent ratio of value and price.“
Mag. Alexander Müller-Vonderlind, Marketing Manager